Skip Navigation

NDT Plus 2008 1(Supplement 4):iv51-iv55; doi:10.1093/ndtplus/sfn125
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Holmes, C. J.
Right arrow Articles by Smit, W.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

This article appears in the following NDT Plus issue: Dialysis Initiatives May 2007, Berlin, Germany [View the issue table of contents]

Future technologies and techniques in peritoneal dialysis—opportunities and challenges ahead

Clifford J. Holmes1 and Watske Smit2,3

1 Renal Division, Baxter Healthcare, IL, USA
2 Department of Nephrology, Academic Medical Center, University of Amsterdam
3 Renal Division, Baxter Healthcare, Utrecht, The Netherlands

Correspondence: Clifford J. Holmes, Baxter Healthcare, 1620 Waukegan Road, William Graham Building, Mail code MPGR-A2N, McGaw Park, IL 60085, USA. Tel: +1-847-473-6352; Fax: +1-847-473-6902; E-mail: cliff_holmes{at}baxter.com


   Abstract

In the last 5 years, we have started to witness the emergence of new technologies and techniques that offer the potential for improved patient outcomes but which often still lack clinical demonstration and/or confirmation in well-designed, multicentre studies. These include biocompatible solutions, glucose sparing regimens, low-sodium solutions, bimodal solution formulations and continuous flow peritoneal dialysis (CFPD). This review discusses the potential benefits ascribable to each of these technologies and an analysis of the challenges that have to be surmounted before anyone of these candidate technologies can be declared as established. The demonstration of either hard clinical endpoints or validated surrogate endpoints is very feasible in terms of sample size requirements for some outcome measures, such as preservation of RRF, but will be much more challenging for other endpoints such as preservation of UF capacity.

Key Words: future • peritoneal dialysis • technologies • techniques

Received for publication February 19, 2008. Accepted for publication June 19, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.